esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) histlogically confirmed esophageal cancer 2) planning to undergo transthoracic esophagectomy and stomach reconstruction 3) WBC: 3000 /mm3>=, =<12000/mm3 and NE: >=1500 mm3 and PLT: >=100000 /mm3 and Hb: >=9.5 g/dL and GOT, GPT: < 1.5 times of institutional upper limit and T-Bil: =<1.5 g/dL and ALP: < 2.5 times of institutional upper limit and Cr: =<1.5 mg/dL and Alb: >=2.8g/dL 4) Written informed concent
Exclusion criteria
Exclusion criteria: 1) history of receiving gastrectomy 2) taking trace element 3) liver disease, mental disease, convulsive seizure, seizure disorder, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes mellitus, autoimmune disease 4) history of severe adverse event due to ELNEOPA(R) or RACOL(R) 5) contraindication to ELNEOPA(R) or RACOL(R) 6) pregnancy 7) judged inadequate to this study by chief doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change ratio of diamin oxidase (DAO) activity on the day before operation and 3rd and 7th day after operation | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of serum albumin, total protein and trace element concentration on the day before operation and 3rd and 7th day after operation | — |
Countries
Japan